Cleared Traditional

K191989 - WVSM (Wireless Vital Signs Monitor) RWC + miniCap

K191989 is an FDA 510(k) clearance for WVSM (Wireless Vital Signs Monitor) RWC..., manufactured by Athena Gtx. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 188-day FDA review.

K191989 · Athena Gtx · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
188d
Days
Class 2
Risk

K191989 is an FDA 510(k) clearance for the WVSM (Wireless Vital Signs Monitor) RWC + miniCap. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Athena Gtx (Johnson, US). The FDA issued a Cleared decision on January 29, 2020 after a review of 188 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Athena Gtx devices

FDA 510(k) Submission Details - K191989

510(k) Number K191989 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2019
Decision Date January 29, 2020
Days to Decision 188 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d slower than avg
Panel avg: 125d · This submission: 188d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 253
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K191989.
Oxi-W System
K200141 · Ld Technology, LLC · Apr 2020
Masimo Centroid System
K191882 · Masimo Corporation · Apr 2020
Masimo Rad-97 Pulse CO-Oximeter and Accessories, Masimo Radical-7 Pulse CO-Oximeter and Accessories, Masimo Radius-7 Pulse CO-Oximeter and Accessories
K193242 · Masimo Corporation · Feb 2020
Eko Analysis Software
K192004 · Eko Devices, Inc. · Jan 2020
Masimo Rad-97 and Accessories
K191059 · Masimo Corporation · Dec 2019
T3 Platform software
K190273 · Etiometry, Inc. · Dec 2019